Back Cover: The Integrin Ligand c(RGDf(NMe)Nal) Reduces Neointimal Hyperplasia in a Polymer‐Free Drug‐Eluting Stent System (ChemMedChem 7/2014). Issue 7 (July 2014)

• Record Type: Journal Article
• Authors: Rechenmacher, Florian; Steigerwald, Kristin; Laufer, Burkhardt; Neubauer, Stefanie; Kapp, Tobias G.; Li, Liang; Mas‐Moruno, Carlos; Joner, Michael; Kessler, Horst
• Is Part Of: ChemMedChem. Volume 9:Issue 7(2014:Jul.)
• Page Start: 1620
• Page End: 1620
• Publication Date: 2014-07
• Subjects: Pharmaceutical chemistry -- Periodicals; 615.19005
• DOI: 10.1002/cmdc.201490027
• Languages: English
• ISSNs: 1860-7179

Abstract

<abstract abstract-type="graphical" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <p> <bold>The back cover picture shows</bold> the release of the peptidic integrin ligand <italic>c</italic>(RGDf(<italic>N</italic>Me)Nal) from a polymer‐free drug‐eluting stent to inhibit smooth muscle cell proliferation and as a consequence to reduce neointimal hyperplasia. For more details, see the Full Paper by Horst Kessler et al. on <ext-link ext-link-type="doi" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">p. 1413 ff.</ext-link><boxed-text content-type="graphic" position="anchor" orientation="portrait"><graphic position="anchor" mimetype="image" xlink:href="ark:/27927/pghnnqkhkd" orientation="portrait" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></boxed-text></p> </abstract>